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ABSTRACT  
The objective of the work is to recognize the recent advancements in the modern health care and drug delivery systems. The article describes 
few recent developments in technology like artificial intelligence, personalized medicines, customized medicines, 3D printing, bioelectronic 
devices and tele pharmacy, which have the potential to augment health care and drug delivery in coming times. Personalized medication 
ensures precise health care as per the individual genetic makeup of the patients. The 3D printing technology enables to deliver tailor made 
solutions to fulfil individual patient requirements. Bioelectronic medicines and devices are new technology where the patient wears a device 
and its electrical signal cures certain ailments. Tele pharmacy ensures that the technological advances of telecommunications are also passed 
on to the patient health care sector. Moreover, it can be said that all these modern developments ensure that the quality of life improves and 
there comes a better control on the health care costs.  
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Introduction 
As technology develops and knowledge of various 
fields increase, then the quality of life should also improve. 
Ironically modern times has brought many new diseases and 
dreaded ailments also. But the logical and rational use of 
scientific knowledge can surely be helpful in overcoming and 
finding cure to many diseases. Few technology 
advancements like artificial intelligence, personalized 
medicines, customized medicines, 3D printing, bioelectronic 
devices and tele pharmacy. The current method of diagnosis 
and treatment of diseases can be said to be kind of “one pill 
fits all” approach. The underlying problem of such an 
approach is that all patients do not react in the similar 
fashion to the same line treatment. Hence there arises a need 
to identify the specific cause which is the root cause of 
difference in reaction to same medicaments. The future of 
medical treatments will be oriented towards shifting the 
focus to personalized medications. The comparison of 
conventional treatment and personalized treatment is 
depicted in Figure 1.  
Artificial Intelligence is the branch of computer 
science which aids in problem solving by help of symbolic 
programming. Over the recent years it has evolved hugely 
into a science that has applications in health care, 
engineering and business arena. Artificial intelligence was 
born in 1956. [1] The use of various modern technologies in 
pharmacy profession to be potential for growth in this sector 
is unavoidable. The usage of artificial intelligence in 
discovering the drug is having an edge over traditional 
methods due to the ability that it targets the proteins whose 
structure is not well defined. The main aim of this 
development in pharmacy is to generate systems that can 
function intelligently and independently, and can evaluate 
human perception, speech recognition, decision making and 
conversions between languages in the analysis of 
complicated medical data by using composite algorithms and 
software. [2] The scope for use of automation and robotics in 
a range of pharmaceuticals, chemical analysis and the 
developments in dissolution testing and the analytics 
processing of metered-dose inhalers are immense. Although 
the level of judgement and expertise that pharmacists 
provide can’t be replaced by robots, but they are taking 
routine tasks such as counting pills, spot and gas welding, 
sealing assembly and handling various tools. It not only 
rescues the time and cost that is needed for drug 
development but also make the pharmacy profession more 
efficient.[3] [4]  
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3D Printing  
3D Printing technology has the potential to have a great 
positive impact on the medical devices industry and 
pharmaceutical industry. Although this technology has been 
there since long time, only recently it has caught the 
attention of public and the USFDA has already given approval 
of 3D tablets and other medical devices. The process of this 
technique which is also known as additive manufacturing 
based on advanced technologies processed in 
pharmaceuticals is to make 3D solid objects from a 
digitalized file. It is 2D printing-several many times, where 
the printer heap layers to originate parts, the prospective 
impact of 3D printing have shaken up many clinical trials and 
it is easier to upgrade single dosage form unit based on 
patient’s height, weight and had a great impact on 
requirements of all drugs for therapy.[5] 
 
 
Figure 1: Conventional medication and personalized medications 
The quantity of scientific papers recorded in Web of Science 
Core Collection containing a term B3D printing^ or B3D 
printed^ in the title increased from 59 in 2012 to 1573 in 
2017. Moreover, the number of citations of these papers has 
drastic change in growing from 209 to 12,411 within same 
period. Narrowing the searching results to the category of 
pharmacy/pharmacology gives no result in 2012, however 
77 records were found up to 2017, which also shows a great 
interest in the 3DP methods in pharmaceutical sciences.[6] 
Fused deposition modeling (FDM), a type of 3D printing 
technology, is the most estimated in production of dosages 
forms because of the printers; printing precision, 
fundamental to guaranteeing medicine quality parameters; 
and hot-melt extrusion are very inexpensive. The main 
methods are based on powder solidification, liquid 
solidification and extrusion. [7] 
 
 
Figure 2: The progress of 3D printing technologies is explained in above diagram. 
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The 3D printing technique gained an importance in the 
pharmaceutical and medical applications due to the 
possibility of rapid preparation of tailor-made objects which 
could be applied in personalized therapy or medicine. It is 
still a requirement to do investigation of possible ways with 
latent to generate the selected release drug delivery systems 
in freeform structures. 
 
 
Figure 3: Fused Deposition Modeling printers 
 
Fused Deposition Modeling printers use a thermoplastic 
filament, which is heated to its melting point and then 
extruded, layer by layer, to create a three-dimensional 
object. Each 3D printer which works according to a different 
mode requires enough material to be solidified and 
subsequent object fabrication. Despite of the diversity of 3D 
Printing methods, preparation of 3D-printed object includes 
several stages & the design of 3D object with computer-
aided design software and optimization of the geometry 
according to printer specification,& the export of 3D model 
to a common and printer recognizable file format e.g. 
Standard Triangle Language which includes only 3D 
geometry in form of each vertex position data or OBJ in 
which additionally information about polygonal faces or 
color texture are coded,& the import of the file to the 
software and generation of layers which will be printed; the 
height of the printed layer essentially influences the quality 
of the printed object as well as printing times & the 
fabrication of the object by subsequent application (or 
solidification) of the material layers dedicated to the specific 
printing method. [8] 
Tele Pharmacy  
The Model State Pharmacy Act and Model Rules of the 
National Association of Boards of Pharmacy (Model Act) 
defines the practice of tele-pharmacy as “the provision of 
pharmacist care by registered pharmacies and pharmacists 
located within U.S. jurisdictions through the use of 
telecommunications or other technologies to patients or 
their agents at distances that are located within U.S. 
jurisdictions” and provides definitions of related terms (i.e., 
coordinating pharmacy, remote pharmacy, and remote 
dispensing site)1.Basically, Tele pharmacy is the use of 
telecommunications technology to provide pharmacist 
services to distant populations. Tele pharmacy services may 
include drug review/monitoring, provision of drug 
information, medication dispensing, verification of oral and 
sterile compounding, patient assessment, patient counseling 
and medication therapy management. The implementation 
of tele pharmacy systems is rapidly expanding due to the 
increasing affordability of videoconferencing technology and 
the increasing capability of the pharmacist to securely access 
electronic patient health records and perform traditional 
pharmacy practice activities remotely via the Internet. The 
number of scientifically rigorous evaluations of tele 
pharmacy has not kept pace with the rate of tele pharmacy 
adoption. [9] 
Tele pharmacy undoubtedly is a great concept, but it is 
sometimes challenging to put into practice. Inherent to the 
adoption of these practices are legal challenges and pitfalls 
that need to be addressed. The start-up of tele pharmacy 
(hardware, software, connectivity, and operational cost) 
involves considerable time, effort, and money. For rural 
hospitals with fewer patients, the issue of costs appears to 
be one of the biggest barriers to tele pharmacy services. 
Moreover, execution and implementation of comprehensive 
and uniform tele pharmacy law is still a challenge. A well-
developed system, however, can change the practice of 
pharmacy that is beneficial to both the rural communities 
and the hospitals or retail pharmacies that deliver these 
services. [10] 
A literature review was conducted on basis of BIOMED 
CENTRAL and COCHRANE @ OVID databases. The keywords 
“Tele-Pharmacy”, “e-Pharmacy” and “India” were used. The 
topics were selected to limit the citations with summaries, 
for the year between 2010 and 2014, in English. Almost 
twenty articles were used in this study. The word “Tele-
Medicine” was also added to figure articles relating Tele-
Pharmacy. Now, just ten articles not including “Tele-
Pharmacy” were found, which showed the lack of articles on 
the boundary Tele-Pharmacy and E-Pharmacy. [11] 
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Figure 4: Tele pharmacy and its applications 
 
 Traditional Pharmacy by virtual medical 
consultation 
It diagnosed the provided signs and symptoms and 
gives a complete inventory of prescribed and 
nonprescribed drugs, including upfront solutions such 
as health and beauty tips, and beneficial items. [12] 
 Remote diagnosis Sites 
This model is used by a pharmacist at a central 
common pharmacy site who is providing a rural 
community a short distance away and who does not 
wish to manage two different prescription drug 
inventories at both the central pharmacy and remote 
site. 
 Electronic prescription by Hospital Tele pharmacy 
The hospital pharmacist has an approach to the 
patient’s electronic medical records, and checks the 
prescription for proper dosing, allergies, imitation of 
drug therapy and drug interactions. Then the 
pharmacist electronically approves the dispensing of 
the prescription through a specialized electronic 
device. 
 Automated Dispensing Machines (Digital 
pharmacy) 
The prescriber’s drug order is provided to the licensed 
pharmacist at a central pharmacy site electronically or by 
fax. The licensed pharmacist go through the patient’s profile, 
do the proper effective use of drug review and then 
commands the dispensing machine to release the 
medication. The patient is then advised, by the pharmacist, 
through the computer by audially or visually. [13] 
Personalized medicines 
Personalized Medicines are activity of medical treatment to 
the person’s unique attribute. They are very rangy snappy 
and liberal techniques in the pharmaceutical field that is 
informed by every individual’s genetical property and 
surrounding which they are receptive to beyond doubt 
diseases. [13] At present, personalized medication is mainly 
applied in the following areas for prediction, diagnostics, 
therapeutics (including outcome evaluation) and drug 
development. [14] Also, they have a great impact on 
customized drug delivery system. Personal genomics 
connect genotype to phenotype and provide insight into 
disease. Pharmacogenomics connect genotype to patient 
specified treatment. [14] 
It helps identify the best treatment for an individual, thus 
effectively tailoring and customizing treatment for each one 
by their gene’s information. In many diseases, precision 
medicine depends on molecular biomarkers, molecular 
events that relate to response of the treatment and clinical 
outcome but not necessarily cautious to the disease. 
Currently, almost all programs of precision medicine depend 
on patient’s DNA sample examination, range from highly 
focused to specific regions (a few genes are sequenced), to 
whole-exome (all genes are sequenced) and whole-genome 
(the entire genome is sequenced). [15] 
 
Figure 5: Personalized medicine 
Personalized medicine can be prominent in the medicine 
from reaction to anticipation. [16] Personalized medicine can 
supervise the selection of most favorable therapy and 
minimize trial-and-error prescribing. It can avoid or at least 
reduce adverse drug reactions. It surely will prove to have 
increased patient compliance and hence the quality of life. 
Moreover, it can have a control on the health care cost. [17] 
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Bioelectronics Medicines 
Bioelectronic Medicine (BEM) can change radically improve 
medicine, therapy and brilliantly improve the consequences 
of healthcare. It makes use of electrical, magnetic, optical, 
ultrasound, etc. pulses to affect and alter neurological 
behavior which in turn impacts body tasks as an alternative 
to drug-based involvements. Further, it provides the chances 
for targeted and personalized treatments of neurological 
based diseases and conditions in closed-loop control 
systems. [18] 
 Bioelectronic medicine is a new appeal for treating major 
chronic diseases that could give doctors and patients’ 
alternatives to costly used medicine and may become as 
commonly prescribed as chemical or biological drugs. Some 
researchers and pharmaceutical companies are already 
taking this potential new class of treatments seriously and 
due to promising results, others are expected to follow. [19] 
Imagine a prescription from your doctor, not for tablets but 
for a tiny electrical device implanted on a nerve in your neck. 
The device will monitor and treat your condition — whether 
it is diabetes, asthma, hypertension or even cancer — by 
modulating electrical impulses. [20] 
In clinical trials, they have been increasingly applied 
technology and gaining more popularity. Some devices used 
in curing include cochlear and retinal implants and vagus 
nerve stimulators. However, all cells can be caused by 
electrical inputs which give rise to the chance to broaden the 
use of bioelectronic medicine for treating disease. Electronic 
actuation of non-excitable cells has been shown to lead to 
‘programmed’ cell behavior via application of electronic 
input which alters key biological processes. [21] 
Bioelectronic medicines have a great impact on 
neuromodulation. Figure 6 shows how this technique has a 
hand in treating rheumatoid arthritis. 
 
 
Figure 6: Treatment through bioelectronic devices 
 
Vagus nerve produces the electrical stimulation with a 
bioelectronic device affects splenic T-cells and macrophages 
to decrease production of tumour necrosis factor (TNF), an 
inflammatory mediator, leading to decreased rheumatoid 
arthritis symptoms in some patients. The mode of action of 
the device is as follows. [22] 
1) A microregulator energizes the vagus nerve. The signals 
go through the vagus and splenic nerve trigger depletion in 
the activation of T cells and macrophages in the spleen. 
2) There is a reduced production of systemic inflammation 
mediators and reduced activation of circulating immune 
cells. 
3) This leads to reduced inflammation, joint damage and 
pain.  
Conclusion   
The article describes few recent developments in technology 
like artificial intelligence, personalized medicines, 
customized medicines, 3D printing, bioelectronic devices and 
tele pharmacy, which have the potential to augment health 
care and drug delivery in coming times. Today because of the 
advancement of science man is taking help of artificial 
intelligence in the various operations of pharmaceutical 
industries like automation and robotics in a range of 
pharmaceuticals, chemical analysis and the developments in 
dissolution testing and the analytics processing of metered-
dose inhalers etc. The era of one pill fits all is also going to 
finish as scientists are developing personalized and 
customized drug delivery system based on individual patient 
genetic build up. Pharmacogenetics will be the future of 
treatment in the healthcare arena.  
In the area personalized medication one of technologies 
which is achieving major developments is the 3D printing. 
The possibility of 3D printing for developing dosage forms 
like tablets, capsules to the production of medical devices 
parts can have a huge impact on the way medical care 
industry functions. Bioelectronic devices and medicines will 
be able to modulate neural signaling patterns and hence 
achieve therapeutics effects. Tele pharmacy is basically the 
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use of telecommunications technology that enables 
pharmacists to provide services to the patients who are 
stationed at distant places. In a nutshell all these 
advancements can improve the therapy methods and 
enhance the patient care to a great extent.  
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